NCT07574307 Kinesiotaping in Isolated Meniscus Injuries
| NCT ID | NCT07574307 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bandırma Onyedi Eylül University |
| Condition | Meniscus Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2026-04-01 |
| Primary Completion | 2026-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2026-04-01 with a primary completion date of 2026-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The effect of kinesiotaping on pain and functionality in isolated meniscus injuries.
Eligibility Criteria
Inclusion Criteria: * Ages 18-50 * Knee pain lasting longer than 2 weeks * Having a diagnosis of isolated meniscus injury (grade 1, 2 or 3 meniscus degeneration) confirmed by magnetic resonance imaging (MRI) * Not having undergone knee surgery in the last 6 months * Not having received intraarticular injections in the knee area * Being willing to participate in the study Exclusion Criteria: * Trauma history * Anterior or posterior cruciate ligament injury * Collateral ligament injuries * Advanced knee osteoarthritis * Rheumatic or neurological disease * Allergy or skin condition to kinesiotape * History of intraarticular injection * Neuromuscular dysfunction * Rheumatological disease * Cognitive dysfunction
Contact & Investigator
Nurten NAS KIRDAR, Assistant Professor
PRINCIPAL INVESTIGATOR
Bandırma Onyedi Eylül University
Frequently Asked Questions
Who can join the NCT07574307 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Meniscus Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07574307 currently recruiting?
Yes, NCT07574307 is actively recruiting participants. Contact the research team at nkirdar@bandirma.edu.tr for enrollment information.
Where is the NCT07574307 trial being conducted?
This trial is being conducted at Balıkesir, Turkey (Türkiye).
Who is sponsoring the NCT07574307 clinical trial?
NCT07574307 is sponsored by Bandırma Onyedi Eylül University. The principal investigator is Nurten NAS KIRDAR, Assistant Professor at Bandırma Onyedi Eylül University. The trial plans to enroll 75 participants.